Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
COURAGE-ALS Trial: Reldesemtiv Fails to Slow ALS Progression
April 2025
Reldesemtiv fails to slow ALS progression in COURAGE-ALS trial, highlighting challenges in ALS treatment development.
Read more
15 Mar 2025
Ultrasound Neuromodulation Offers Hope for Younger Patients with Alzheimer’s
Ultrasound therapy boosts cognition in younger Alzheimer’s patients. Study highlights TPS as a potential add-on treatment.
13 Mar 2025
Parkinson’s Disease Cases Predicted to Double by 2050: Global Study
Parkinson’s disease cases are set to double by 2050 due to ageing populations. Study highlights urgent need for action.
13 Mar 2025
Researchers Have Identified Gut Microbiome Ratios Linked to Multiple Sclerosis
Gut microbiome study identifies microbial ratio linked to multiple sclerosis severity, offering potential for diagnostics and therapies.
11 Mar 2025
Semaglutide Reduces Alcohol Cravings in Adults with Alcohol Use Disorder
Low-dose semaglutide reduces alcohol cravings and some drinking behaviours in adults with alcohol use disorder.
9 Mar 2025
Nasal Spray Immunomodulation: A Novel Approach to Treating TBI
Nasal spray shows promise in treating traumatic brain injury by reducing inflammation and enhancing immune cell function in mouse models.
7 Mar 2025
4D Brain Map Uncovers Early Signs of Multiple Sclerosis
New 4D brain map unveils early warning signs and potential therapeutic targets for multiple sclerosis, offering hope for improved treatments.
4 Mar 2025
New Study Shows Haemorrhagic Strokes Double Dementia Risk
Brain haemorrhages double dementia risk, urging regular cognitive screening for affected patients. New research highlights critical clinical implications.
2 Mar 2025
Tetramethylpyrazine Nitrone Benefits Grip Strength in Younger Patients with ALS
A clinical trial finds tetramethylpyrazine nitrone safe for ALS, with potential benefits in grip strength for younger patients.
Loading posts...
« Previous
1
2
3
4
…
38
Next »